Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747)

Affiliations

¹ 1 Department of Medicine, University of Michigan , Ann Arbor, Michigan.
² 2 Department of Endocrinology, Erasmus University Medical Center , Rotterdam, Netherlands .

Comment

Terry J Smith et al. Thyroid. 2017 Nov.

. 2017 Nov;27(11):1458-1459.

doi: 10.1089/thy.2017.0281. Epub 2017 Sep 28.

¹ 1 Department of Medicine, University of Michigan , Ann Arbor, Michigan.
² 2 Department of Endocrinology, Erasmus University Medical Center , Rotterdam, Netherlands .

No abstract available

Comment in

Rebuttal to Smith and Janssen (Thyroid 2017;27:746-747. DOI: 10.1089/thy.2017.0281).
Neumann S, Gershengorn MC. Neumann S, et al. Thyroid. 2017 Nov;27(11):1459-1460. doi: 10.1089/thy.2017.0472. Epub 2017 Oct 17. Thyroid. 2017. PMID: 28922977 Free PMC article. No abstract available.

Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.
Smith TJ, Janssen JA. Smith TJ, et al. Front Endocrinol (Lausanne). 2017 Jan 3;7:167. doi: 10.3389/fendo.2016.00167. eCollection 2016. Front Endocrinol (Lausanne). 2017. PMID: 28096798 Free PMC article. Review.
TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis.
Krieger CC, Neumann S, Marcus-Samuels B, Gershengorn MC. Krieger CC, et al. Thyroid. 2017 May;27(5):746-747. doi: 10.1089/thy.2017.0105. Epub 2017 Mar 27. Thyroid. 2017. PMID: 28346855 Free PMC article. No abstract available.

1. Krieger CC, Neumann S, Marcus-Samuels B, Gershengorn MC. 2017. TSHR/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates Graves' ophthalmopathy pathogenesis. Thyroid 27:746–747 - PMC - PubMed
1. Smith TJ, Janssen JAMJL. 2017. Building the case for insulin-like receptor-1 involvement in thyroid-associated ophthalmopathy. Front Endocrinol 7:167 - PMC - PubMed
1. Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. 2008. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol 181:4397–4405 - PMC - PubMed
1. Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. 2003. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol 170:6348–6354 - PubMed
1. Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ. 2004. Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol 173:3564–3569 - PubMed